These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 1796293)
1. Fibrinolysis: past and present, a reflection of fifty years. Astrup T Semin Thromb Hemost; 1991 Jul; 17(3):161-74. PubMed ID: 1796293 [No Abstract] [Full Text] [Related]
2. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system. Sindet-Pedersen S Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633 [TBL] [Abstract][Full Text] [Related]
3. Hemostasis, fibrinolysis, and natural anticoagulation in transplant vascular sclerosis. Faulk WP; Labarrere CA; Nelson DR; Pitts D J Heart Lung Transplant; 1995; 14(6 Pt 2):S158-64. PubMed ID: 8719478 [No Abstract] [Full Text] [Related]
5. Profibrinolytic and antifibrinolytic effects of platelets. Devine DV; Carter CJ Coron Artery Dis; 1995 Dec; 6(12):915-22. PubMed ID: 8723012 [TBL] [Abstract][Full Text] [Related]
9. Diabetes mellitus as a prothrombotic condition. Grant PJ J Intern Med; 2007 Aug; 262(2):157-72. PubMed ID: 17645584 [TBL] [Abstract][Full Text] [Related]
10. [Advances in fibrinolysis mediated by vascular endothelial cells]. Zhou QS Sheng Li Ke Xue Jin Zhan; 1990 Oct; 21(4):318-22. PubMed ID: 2129251 [No Abstract] [Full Text] [Related]
11. Visceral fat as a determinant of fibrinolysis and hemostasis. Mertens I; Van Gaal LF Semin Vasc Med; 2005 Feb; 5(1):48-55. PubMed ID: 15968580 [TBL] [Abstract][Full Text] [Related]
12. Diet, blood coagulation and fibrinolysis. Marckmann P Dan Med Bull; 1995 Nov; 42(5):410-25. PubMed ID: 8747799 [No Abstract] [Full Text] [Related]
13. [Plasminogen tissue activator and plasminogen tissue inhibitor in type II diabetes]. Rość D; Drewniak W; Kotschy M; Graczykowska-Koczorowska A; Raukuć D Pol Merkur Lekarski; 1997 Jan; 2(7):24-5. PubMed ID: 9296893 [TBL] [Abstract][Full Text] [Related]
14. Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during retransfusion of shed blood after cardiopulmonary bypass. de Haan J; Schönberger J; Haan J; van Oeveren W; Eijgelaar A J Thorac Cardiovasc Surg; 1993 Dec; 106(6):1017-23. PubMed ID: 8246533 [TBL] [Abstract][Full Text] [Related]
15. [Fibrinolysis process in prostatic carcinoma]. Zietek Z; Iwan-Zietek I; Kotschy M; Tyloch F Pol Tyg Lek; 1996 Feb; 51(6-9):107-8. PubMed ID: 8756748 [No Abstract] [Full Text] [Related]
16. [Significance of the activity of indicators of the fibrinolytic system on assessment of the hemostatic state]. Savchuk OM; Hamisoniia MSh; Kizim OI; Platonova TM Fiziol Zh (1994); 2001; 47(3):58-63. PubMed ID: 11519252 [TBL] [Abstract][Full Text] [Related]
17. [Catecholamines and activation of fibrinolysis]. Zhu GJ Sheng Li Ke Xue Jin Zhan; 1991 Jan; 22(1):62-4. PubMed ID: 1648257 [No Abstract] [Full Text] [Related]
18. [Biochemical and physiologic principles of tissue-type plasminogen activator]. Lill H Z Gesamte Inn Med; 1987 Sep; 42(17):478-86. PubMed ID: 3120429 [TBL] [Abstract][Full Text] [Related]
19. [Peritoneal mesothelium--the role in fibrin transformations]. Winckiewicz M; Staniszewski R; Połubińska A; Breborowicz A Przegl Lek; 2006; 63(9):778-81. PubMed ID: 17479869 [TBL] [Abstract][Full Text] [Related]